Orion Therapeutics, Inc.

New Filing
CIK: 0001958173·Biotechnology·DELAWARE·Filed: Sep 25, 2024
Total Offering

$250,000

Amount Sold

$85,000

Investors

4

First Sale

Sep 10, 2024

Offering Details

Type
Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
Yes

Related Persons

NameRole
Richard Kern Fisher
Related Person
Michael McCaman
Related Person
Deidra Mountain
Related Person

Company

Orion Therapeutics, Inc.

2641 OSPREY VISTA WAY

KNOXVILLE, TN, 37920

865-771-7024

SEC Filing

0001958173-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Orion Therapeutics, Inc. Form D Filing — $250,000 | FilingFlow